# FDA Inspection 1224630 - Biomat USA, Inc. - November 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3f382c20-cb24-4bef-ad5d-6943a5912396
Source feed: FDA_Inspections

> FDA Inspection 1224630 for Biomat USA, Inc. on November 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224630
- Company Name: Biomat USA, Inc.
- Inspection Date: 2023-11-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/biomat-usa-inc/6637e6c1-b6bb-400c-9dcb-d0ab405ef970

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d